Alta Partners Management Company, L.P. Tyra Biosciences, Inc. Transaction History
Alta Partners Management Company, L.P.
- $63.4 Billion
- Q4 2024
A detailed history of Alta Partners Management Company, L.P. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Alta Partners Management Company, L.P. holds 4,080,296 shares of TYRA stock, worth $54.5 Million. This represents 89.47% of its overall portfolio holdings.
Number of Shares
4,080,296Holding current value
$54.5 Million% of portfolio
89.47%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
101Shares Held
47.2MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$139 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$86.1 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$62.2 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$55.8 Million97.27% of portfolio
-
Nextech Invest Ag4.06MShares$54.1 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $560M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...